Professor of Medicine (Cardiology), Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City School of Medicine
Cardiology
Dr. Mikhail Kosiborod, MD
|
|
Give Review
Mikhail Kosiborod works in the field of Cardiology. He went to medical school at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Doctor Mikhail Kosiborod, MD is a published physician as well. He has 85 publications published. The latest was: Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalemia. Mikhail Kosiborod is registered with Medicare.
Publications
- Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalemia.
- Long-term excess risk of Heart failure in people with type 1 diabetes: a prospective case-control study.
- Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable Angina according to baseline hemoglobin A1c.
- Prevalence of glucose abnormalities among patients presenting with an Acute myocardial infarction.
- Type of β-blocker use among patients with versus without diabetes after Myocardial infarction.
- Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial.
- Effects of Ranolazine on Quality of Life Among Patients With Diabetes Mellitus and Stable Angina.
- Association between diabetes mellitus and Angina after acute myocardial infarction: analysis of the TRIUMPH prospective cohort study.
- Inpatient dysglycemia and clinical outcomes: Association or causation?
- Patterns of Statin Initiation, Intensification, and Maximization Among Patients Hospitalized with an Acute Myocardial Infarction.
- Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the NCDR Cath-PCI Reg...
- Variation in the Incidence of Hospital-Acquired Anemia During Hospitalization With Acute Myocardial Infarction (Data from 57 US Hospitals).
- Patterns and Predictors of Intensive Statin Therapy Among Patients With Diabetes Mellitus After Acute Myocardial Infarction.
- Association between Admission Hyperglycemia During Hospitalization for Acute Myocardial Infarction and Subsequent Diabetes: Insights from the Veterans Administration C...
- Temporal trends and hospital variation in the management of severe hyperglycemia among patients with Acute myocardial infarction in the United States.
- Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.
- The Reliability and Prognosis of In-Hospital Diagnosis of Metabolic Syndrome in the Setting of Acute Myocardial Infarction.
- The Synergistic Relationship Between Estimated GFR and Microalbuminuria in Predicting Long-term Progression to ESRD or Death in Patients With Diabetes: Results From th...
- Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 Annual Data R...
- Nuisance Bleeding With Prolonged Dual Antiplatelet Therapy After Acute Myocardial Infarction and its Impact on Health Status.
- Evaluation of Ranolazine in Patients with Type 2 Diabetes Mellitus and Chronic Stable Angina. Results from the TERISA randomized clinical trial.
- Performance of the Medtronic Sentrino continuous glucose management (CGM) system in the cardiac intensive care unit.
- Age at diagnosis predicts deterioration in glycaemic control among children and adolescents with type 1 diabetes.
- The reliability of in-hospital diagnoses of diabetes mellitus in the setting of an Acute myocardial infarction.
- Validated Contemporary Risk Model of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights From the National Cardiovascular Data Reg...
- Acute and chronic cardiovascular effects of hyperkalemia: new insights into prevention and clinical management.
- Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit.
- Antiplatelet therapy use after discharge among Acute myocardial infarction patients with in-hospital bleeding.
- ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation Myocardial infarction: a report of the American College of Cardiology/American Hear...
- Intensive glucose control and cardiovascular outcomes.
- Serum complement activation in congestive Heart failure.
- Hospital-wide code rates and mortality before and after implementation of a rapid response team.
- Impact of anemia on physical function and survival among patients with Coronary artery disease.
- Careers in cardiovascular outcomes research.
- Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with Acute myocardial infarction.
- Elevated admission glucose and mortality in elderly patients hospitalized with Heart failure.
- Glucose normalization and outcomes in patients with Acute myocardial infarction.
- Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of Acute myocardial infarction.
- Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the Americ...
- Trends in the incidence of Acute kidney injury in patients hospitalized with Acute myocardial infarction.
- Diagnostic blood sampling: how much is too much?
- Serum potassium levels and mortality in Acute myocardial infarction.
- Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline.
- Hypoglycemia and adverse outcomes: marker or mediator?
- Piloting a novel algorithm for glucose control in the Coronary care unit: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial.
- Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with Atrial fibrillation.
- Hospital-acquired anemia and in-hospital mortality in patients with Acute myocardial infarction.
- Diagnostic blood loss from phlebotomy and hospital-acquired anemia during Acute myocardial infarction.
- Recovery From Hospital-Acquired Anemia After Acute Myocardial Infarction and Effect on Outcomes.
- Glucose-lowering targets for patients with cardiovascular disease: focus on inpatient management of patients with Acute coronary syndromes.
- Continuous glucose monitoring during critical care.
- Outcomes research: the next generation.
- Outcomes associated with anemia in patients with Heart failure.
- Trends in length of stay and short-term outcomes among Medicare patients hospitalized for Heart failure, 1993-2006.
- Incidence, correlates, and outcomes of Acute, hospital-acquired anemia in patients with Acute myocardial infarction.
- Importance of measuring glycosylated hemoglobin in patients with Myocardial infarction and known diabetes mellitus.
- Pre-procedural glucose levels and the risk for contrast-induced Acute kidney injury in patients undergoing coronary angiography.
- Discontinuation of antihyperglycemic therapy and clinical outcomes after Acute myocardial infarction in older patients with diabetes.
- An overview of glycemic control in the Coronary care unit with recommendations for clinical management.
- Association of longitudinal measures of hemoglobin and outcomes after hospitalization for Heart failure.
- Training programs in outcomes research: the "field guide" for current opportunities.
- Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous Coronary interv...
- Variation in glycemia in patients hospitalized with Acute myocardial infarction. Is it time for glucose monitoring?
- Comparison of incidence of Acute myocardial infarction in patients with type 2 diabetes mellitus following initiation of neutral protamine Hagedorn insulin versus insu...
- Blood glucose and its prognostic implications in patients hospitalised with Acute myocardial infarction.
- Utility estimates for decision-analytic modeling in chronic Heart failure--health states based on New York Heart Association classes and number of rehospitalizations.
- Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity...
- Glucometrics in patients hospitalized with Acute myocardial infarction: defining the optimal outcomes-based measure of risk.
- The relationship between anemia, change in hematocrit over time and change in health status in patients with Heart failure after myocardial infarction.
- Predictors of weight change in overweight patients with Myocardial infarction.
- Changes in outcomes for internal medicine inpatients after work-hour regulations.
- Identifying Heart failure patients at high risk for near-term cardiovascular events with serial health status assessments.
- Self-reported use of complementary and alternative medicine in patients with previous Acute coronary syndrome.
- Usefulness of myocardial contrast echocardiography in predicting late mortality in patients with anterior wall Acute myocardial infarction.
- National trends in outcomes among elderly patients with Heart failure.
- Admission body temperature and mortality in elderly patients hospitalized for Heart failure.
- Anemia and outcomes in patients with Heart failure: a study from the National Heart Care Project.
- Relation of anemia at discharge to survival after Acute coronary syndromes.
- Assessment of right ventricular morphology and function.
- Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project.
- Admission glucose and mortality in elderly patients hospitalized with Acute myocardial infarction: implications for patients with and without recognized diabetes.
- The obesity paradox: body mass index and outcomes in patients with Heart failure.
- Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with Heart failure?
- The prognostic importance of anemia in patients with Heart failure.
Schools
Mount Sinai School Of Medicine Of New York University
Yale New Haven Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
Yale-New Haven Hospital -
Icahn School of Medicine at Mount Sinai
Drug Facts
| NPI NUMBER | 1588613657 | |
| NPPES Provider LastName | KOSIBOROD | |
| NPPES Provider FirstName | MIKHAIL | |
| NPPES Provider ZIPCode | 641115939 | |
| NPPES Provider State | MO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 1165.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588613657 |
| Last Name Of The Provider | KOSIBOROD |
| First Name Of The Provider | MIKHAIL |
| View All |
Similar Doctors
|
|
Dr. Andrew C. Kao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William N. Brodine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bethany A. Austin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adnan K. Chhatriwalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David M. Safley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas H. Good, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark P. Everley, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Patrick Santiago, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Holkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan P. Wimmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David G. Skolnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carlos E. Rivas-Gotz, MD |
|
|
Dr. Matthew G. Deedy, MD
This Doctor is OpenDoctor Recommended.
|